No black box warning on record for Olfoxacin Otic Soln

As of the latest FDA labeling reviewed, Olfoxacin Otic Soln (OLFOXACIN OTIC SOLN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Olfoxacin Otic Soln medicine page for the complete safety profile.

Other warnings & precautions

NOT FOR OPHTHALMIC USE. NOT FOR INJECTION. Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolones, including ofloxacin. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, angioedema (including laryngeal, pharyngeal or facial edema), airway obstruction, dysp

No black box warning on record for Olfoxacin Otic Soln

Other warnings & precautions

NOT FOR OPHTHALMIC USE. NOT FOR INJECTION. Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolones, including ofloxacin. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, angioedema (including laryngeal, pharyngeal or facial edema), airway obstruction, dysp

Olfoxacin Otic Soln Black Box Warning

No black box warning on record for Olfoxacin Otic Soln

Other warnings & precautions

Olfoxacin Otic Soln Black Box Warning

No black box warning on record for Olfoxacin Otic Soln

Other warnings & precautions